Autoimmune Disease Clinical Trials

56 clinical trials for Autoimmune Disease across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals — RECRUITING · PHASE2
• Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy — RECRUITING · PHASE2
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO — RECRUITING · PHASE1
• Natural History of Bronchiectasis — RECRUITING
• Autoimmune and Autoinflammatory Genetics Study — RECRUITING
• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors — RECRUITING
• A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. — RECRUITING · PHASE1
• The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing — RECRUITING
• A PHASE 2/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF ORAL BREPOCITINIB IN ADULTS WITH LICHEN PLANOPILARIS — RECRUITING · PHASE2
• A PHASE 1 OPEN-LABEL, MULTIREGIONAL, MULTICENTER, BASKET STUDY EVALUATING THE SAFETY AND EFFICACY OF KITE-363, AN AUTOLOGOUS ANTI-CD19/CD20 CAR T-CELL THERAPY IN PARTICIPANTS WITH REFRACTORY AUTOIMMUNE DISEASES — RECRUITING · PHASE1
• A PHASE 1 STUDY EVALUATING THE SAFETY AND PRELIMINARY EFFICACY OF ALLO- 329, A DUAL ANTI-CD19 / ANTI-CD70 ALLOGENEIC CAR T CELL PRODUCT IN AUTOIMMUNE DISEASE (RESOLUTION) — RECRUITING · PHASE1
• Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases — RECRUITING · NA
• Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases — RECRUITING · NA
• A RANDOMIZED, TWO-PERIOD CROSSOVER STUDY TO DEMONSTRATE THE COMPARABILITY OF PHARMACOKINETICS OF SUBCUTANEOUS IANALUMAB BETWEEN 2ML AUTOINJECTOR/2ML PRE-FILLED SYRINGE WITH 1 ML PRE-FILLED SYRINGE IN ADULT PARTICIPANTS WITH AUTOIMMUNE DISEASE — RECRUITING
• PHASE IB OPEN LABEL BASKET TRIAL OF RAY121 TO INHIBIT CLASSICAL COMPLEMENT PATHWAY IN IMMUNOLOGICAL DISEASES (RAINBOW TRIAL) — RECRUITING · PHASE1
• A THREE-PERIOD MULTICENTER STUDY, WITH A RANDOMIZED WITHDRAWAL, DOUBLE-BLINDED, PLACEBO-CONTROLLED DESIGN TO EVALUATE THE CLINICAL EFFICACY, SAFETY AND TOLERABILITY OF MAS825 IN PATIENTS WITH MONOGENIC IL-18 DRIVEN AUTOINFLAMMATORY DISEASES, INCLUDING NLRC4-GOF, XIAP DEFICIENCY, OR CDC42 MUTATIONS — RECRUITING
• A PHASE IB STUDY OF NIVOLUMAB IN PATIENTS WITH AUTOIMMUNE DISORDERS AND ADVANCED MALIGNANCIES (AIM-NIVO) — RECRUITING · PHASE1
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ONCE-DAILY INHALED MOLGRAMOSTIM NEBULIZER SOLUTION IN ADULT SUBJECTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (APAP) — RECRUITING
• The role of direct immunofluorescence and serologic immunologic assays for the diagnosis of autoimmune dermatose of the skin. — RECRUITING
• Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults. — COMPLETED · PHASE1
• Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease — COMPLETED · PHASE1
• The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD — NOT_YET_RECRUITING · PHASE1
• A PHASE 2A, OPEN-LABEL, MULTICENTER, PLATFORM TRIAL TO ASSESS THE SAFETY, TOLERABILITY, AND EFFICACY OF INEBILIZUMAB AND BLINATUMOMAB IN SUBJECTS WITH SELECT AUTOIMMUNE DISEASES (MASTER PROTOCOL) — COMPLETED · PHASE2
• Immunogenicity of HPV Vaccine in Immunosuppressed Children — COMPLETED · PHASE3
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis — COMPLETED · PHASE2
• Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers — OTHER · PHASE1
• Scleroderma: Cyclophosphamide or Transplantation — COMPLETED · PHASE2
• Aerobic Exercise in Women With Systemic Lupus Erythematosus — TERMINATED · NA
• Continuation of Follow-up of DES-Exposed Cohorts — COMPLETED
• Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases — COMPLETED · PHASE1
• Intravenous Immunoglobulin for PANDAS — COMPLETED · PHASE3
• Identify Clinical Conditions That Increase Circulating DNA Levels — COMPLETED
• Leflunomide Treatment for IgG4-RD — OTHER · NA
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF XMAB®5871 IN PATIENTS WITH IGG4-RELATED DISEASE (INDIGO) — NOT_YET_RECRUITING · PHASE3
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — COMPLETED · PHASE3
• Rituximab for Autoimmune Retinopathy — COMPLETED · PHASE1
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — COMPLETED · PHASE3
• Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases — WITHDRAWN
• On Open-Label Study in Participants With Systemic Lupus Erythematosus — TERMINATED · PHASE3
• Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols — COMPLETED
• Treatment of Autoimmune Thrombocytopenia (AITP) — COMPLETED · PHASE1
• Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study — COMPLETED
• Steroid Therapy in Autoimmune Premature Ovarian Failure — COMPLETED
• A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants — COMPLETED · PHASE1
• 18F-FDG PET/CT for IgG4-Related Disease — OTHER · PHASE1
• Study of Treatment Response on IgG4 Related Disease (IgG4RD) — OTHER · PHASE2
• Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography — COMPLETED
• Sudoscan in Patients With Autoimmune Disorders — COMPLETED

Refine this search